null Amal Idrissi Janati, PhD

Investigator, RI-MUHC, Montreal General Hospital site

Surgical and Interventional Sciences Program


Research Focus

My research focuses on investigating the role of compromised oral health in major health diseases, including colorectal cancer. I also have a particular interest in comparative effectiveness studies based on real-world data and pragmatic trials assessing the effectiveness of surgical and prosthodontic rehabilitation techniques in enhancing both clinical and patient-centred outcomes of patients diagnosed with oral and maxillofacial cancers.

Selected Publications

Click on Pubmed to see my current publications list

  • A. Idrissi Janati, I. Karp, D. Von Renteln, M. Bouin, Y. Liu, S D. Tran, E. Emami. (2022). Investigation of Fusobacterium Nucleatum in saliva and colorectal mucosa: a pilot study. Scientific Reports, 12(1):5622.

  • A. Idrissi Janati, I. Karp, J‑F Latulippe, P. Charlebois, E. Emami. (2022). Periodontal disease as a risk factor for sporadic colorectal cancer: results from COLDENT study. Cancer Causes Control, 33(3):463-472.

  • H. Morsi, M. Golizeh, N. Brosseau, A. Idrissi Janati, E. Emami, M. Ndao, S D. Tran. (2022). Detection of Fusobacterium nucleatum subspecies in the saliva of pre-colorectal cancer patients, using tandem mass spectrometry. Archives of Oral Biology, 134 (2022)-105337.

  • A. Idrissi Janati, I. Karp, C. Laprise, H. Sabri, E. Emami. (2020). Detection of Fusobacterium nucleatum in feces and colorectal mucosa as a risk factor for colorectal cancer: a systematic review and meta-analysis. Systematic Reviews, 9(1):276.

  • A. Idrissi Janati, I. Karp, Hisham Sabri, E. Emami. (2019). Is Fusobacterium nucleatum infection in the colon a risk factor for colorectal cancer? A systematic review and meta-analysis protocol. Systematic Reviews, 8(1):114.